Trial Profile
Phase II trial of darunavir + ritonavir in multiple-PI-experienced patients: TMC114-C207
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Sep 2011
Price :
$35
*
At a glance
- Drugs Darunavir (Primary) ; Ritonavir (Primary)
- Indications HIV infections
- Focus Pharmacogenomic; Therapeutic Use
- Sponsors Janssen R&D Ireland